Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson’s Disease
International Journal of Molecular Sciences · 09.01.2023 · 24 (2) · 1256
DOI: 10.3390/ijms24021256 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.01.2023. Verfasst von Alfredo Gonzalez-Alcocer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Histologia, Facultad de Medicina, Universidad Autonoma de Nuevo Leon, Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico. Hauptthemen laut MEDLINE: Parkinson Disease, Trace Elements. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Programa de Apoyo a la Investigación Científica y Tecnológica (PAICyT), Programa de Apoyo a la Investigacion Cientifica y Tecnologica (PAICyT).
Abstract (Originalsprache)
Biometals are all metal ions that are essential for all living organisms. About 40% of all enzymes with known structures require biometals to function correctly. The main target of damage by biometals is the central nervous system (CNS). Biometal dysregulation (metal deficiency or overload) is related to pathological processes. Chronic occupational and environmental exposure to biometals, including iron and copper, is related to an increased risk of developing Parkinson’s disease (PD). Indeed, biometals have been shown to induce a dopaminergic neuronal loss in the substantia nigra. Although the etiology of PD is still unknown, oxidative stress dysregulation, mitochondrial dysfunction, and inhibition of both the ubiquitin–proteasome system (UPS) and autophagy are related to dopaminergic neuronal death. Herein, we addressed the involvement of redox-active biometals, iron, and copper, as oxidative stress and neuronal death inducers, as well as the current metal chelation-based therapy in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Histologia, Facultad de Medicina, Universidad Autonoma de Nuevo Leon, Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.
- Servicio de Neurocirugía y Terapia Endovascular Neurológica, Hospital Universitario, Dr. Jose Eleuterio Gonzalez, Monterrey 64460, Mexico.
ORCID-Profile: Alfredo Gonzalez-Alcocer, Roberto Montes de Oca-Luna, Aracely Garcia-Garcia, Humberto Rodriguez-Rocha
Förderung
- Programa de Apoyo a la Investigación Científica y Tecnológica (PAICyT)
- Programa de Apoyo a la Investigacion Cientifica y Tecnologica (PAICyT)
Zitieren
APA
Gonzalez-Alcocer, A., Duarte-Jurado, A. P., Soto-Dominguez, A., Loera-Arias, M. J., Villarreal-Silva, E. E., Saucedo-Cardenas, O., de Oca-Luna, R. M., Garcia-Garcia, A., & Rodriguez-Rocha, H. (2023). Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson’s Disease. International Journal of Molecular Sciences, 24(2), 1256. https://doi.org/10.3390/ijms24021256
Vancouver
Gonzalez-Alcocer A, Duarte-Jurado AP, Soto-Dominguez A, Loera-Arias MJ, Villarreal-Silva EE, Saucedo-Cardenas O, et al. Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson’s Disease. International Journal of Molecular Sciences. 2023;24(2):1256. doi:10.3390/ijms24021256
BibTeX
@article{GonzalezAlcocer2023,
author = {Gonzalez-Alcocer, Alfredo and Duarte-Jurado, Ana Patricia and Soto-Dominguez, Adolfo and Loera-Arias, Maria de Jesus and Villarreal-Silva, Eliud Enrique and Saucedo-Cardenas, Odila and de Oca-Luna, Roberto Montes and Garcia-Garcia, Aracely and Rodriguez-Rocha, Humberto},
title = {Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1256},
doi = {10.3390/ijms24021256}
}
EUVIMED